The platform can be harnessed for TB, potentially improving protection and durability of immunity in a way that traditional ...

ImmunityBio has gained US Food and Drug Administration (FDA) authorisation for an expanded access programme to supply an ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA ...

BCG is a benign bacterium originally developed as a live vaccine against tuberculosis (TB). It is based on the well-known Mycobacterium bovis (M. bovis) Bacillus Calmette-Guérin (BCG) strain.

Tuberculosis (TB) in cattle is threat to public health, animal health and trade. The Department and industry invest significant sums in a TB eradication programme each year. Bovine TB is caused by ...

Mammalian hosts coordinate various cell death pathways as part of the immune defense system against pathogens including ...

A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials ...

David Ussery and Brian Delavan discuss bioinformatics into TB surveillance, presenting a new approach to tackling this ...

TBtypeR enables detection of low-frequency mixed-strain Mycobacterium tuberculosis infections from whole genome sequencing data, outperforming existing methods and revealing a higher prevalence of ...

Australian researchers have developed a new mRNA vaccine for tuberculosis, showing effective results in mice. The vaccine enhances immunity and offers better long-term protection compared to the ...